Summary
According to APO Research, The global DPT Vaccines market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for DPT Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for DPT Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for DPT Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for DPT Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of DPT Vaccines include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, KM Biologics, Wuhan Institute of Biological Products, Walvax Biotechnology, Chengdu Institute of Biological Products and Minhai Biotechnology, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for DPT Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of DPT Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for DPT Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the DPT Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global DPT Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for DPT Vaccines sales, projected growth trends, production technology, application and end-user industry.
DPT Vaccines segment by Company
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology
DPT Vaccines segment by Type
DTaP
Tdap
DTwP
DPT Vaccines segment by Age
12 Months Below
12 Months Above
DPT Vaccines segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DPT Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of DPT Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DPT Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of DPT Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of DPT Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, DPT Vaccines sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 DPT Vaccines Market by Type
1.2.1 Global DPT Vaccines Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 DTaP
1.2.3 Tdap
1.2.4 DTwP
1.3 DPT Vaccines Market by Age
1.3.1 Global DPT Vaccines Market Size by Age, 2019 VS 2023 VS 2030
1.3.2 12 Months Below
1.3.3 12 Months Above
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 DPT Vaccines Market Dynamics
2.1 DPT Vaccines Industry Trends
2.2 DPT Vaccines Industry Drivers
2.3 DPT Vaccines Industry Opportunities and Challenges
2.4 DPT Vaccines Industry Restraints
3 Global Market Growth Prospects
3.1 Global DPT Vaccines Revenue Estimates and Forecasts (2019-2030)
3.2 Global DPT Vaccines Revenue by Region
3.2.1 Global DPT Vaccines Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global DPT Vaccines Revenue by Region (2019-2024)
3.2.3 Global DPT Vaccines Revenue by Region (2025-2030)
3.2.4 Global DPT Vaccines Revenue Market Share by Region (2019-2030)
3.3 Global DPT Vaccines Sales Estimates and Forecasts 2019-2030
3.4 Global DPT Vaccines Sales by Region
3.4.1 Global DPT Vaccines Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global DPT Vaccines Sales by Region (2019-2024)
3.4.3 Global DPT Vaccines Sales by Region (2025-2030)
3.4.4 Global DPT Vaccines Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 Market Competitive Landscape by Manufacturers
4.1 Global DPT Vaccines Revenue by Manufacturers
4.1.1 Global DPT Vaccines Revenue by Manufacturers (2019-2024)
4.1.2 Global DPT Vaccines Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global DPT Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global DPT Vaccines Sales by Manufacturers
4.2.1 Global DPT Vaccines Sales by Manufacturers (2019-2024)
4.2.2 Global DPT Vaccines Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global DPT Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global DPT Vaccines Sales Price by Manufacturers (2019-2024)
4.4 Global DPT Vaccines Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global DPT Vaccines Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global DPT Vaccines Manufacturers, Product Type & Application
4.7 Global DPT Vaccines Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global DPT Vaccines Market CR5 and HHI
4.8.2 2023 DPT Vaccines Tier 1, Tier 2, and Tier 3
5 DPT Vaccines Market by Type
5.1 Global DPT Vaccines Revenue by Type
5.1.1 Global DPT Vaccines Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global DPT Vaccines Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global DPT Vaccines Revenue Market Share by Type (2019-2030)
5.2 Global DPT Vaccines Sales by Type
5.2.1 Global DPT Vaccines Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global DPT Vaccines Sales by Type (2019-2030) & (M Doses)
5.2.3 Global DPT Vaccines Sales Market Share by Type (2019-2030)
5.3 Global DPT Vaccines Price by Type
6 DPT Vaccines Market by Application
6.1 Global DPT Vaccines Revenue by Application
6.1.1 Global DPT Vaccines Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global DPT Vaccines Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global DPT Vaccines Revenue Market Share by Application (2019-2030)
6.2 Global DPT Vaccines Sales by Application
6.2.1 Global DPT Vaccines Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global DPT Vaccines Sales by Application (2019-2030) & (M Doses)
6.2.3 Global DPT Vaccines Sales Market Share by Application (2019-2030)
6.3 Global DPT Vaccines Price by Application
7 Company Profiles
7.1 Sanofi Pasteur
7.1.1 Sanofi Pasteur Comapny Information
7.1.2 Sanofi Pasteur Business Overview
7.1.3 Sanofi Pasteur DPT Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Sanofi Pasteur DPT Vaccines Product Portfolio
7.1.5 Sanofi Pasteur Recent Developments
7.2 GSK
7.2.1 GSK Comapny Information
7.2.2 GSK Business Overview
7.2.3 GSK DPT Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 GSK DPT Vaccines Product Portfolio
7.2.5 GSK Recent Developments
7.3 Mitsubishi Tanabe Pharma
7.3.1 Mitsubishi Tanabe Pharma Comapny Information
7.3.2 Mitsubishi Tanabe Pharma Business Overview
7.3.3 Mitsubishi Tanabe Pharma DPT Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Mitsubishi Tanabe Pharma DPT Vaccines Product Portfolio
7.3.5 Mitsubishi Tanabe Pharma Recent Developments
7.4 KM Biologics
7.4.1 KM Biologics Comapny Information
7.4.2 KM Biologics Business Overview
7.4.3 KM Biologics DPT Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 KM Biologics DPT Vaccines Product Portfolio
7.4.5 KM Biologics Recent Developments
7.5 Wuhan Institute of Biological Products
7.5.1 Wuhan Institute of Biological Products Comapny Information
7.5.2 Wuhan Institute of Biological Products Business Overview
7.5.3 Wuhan Institute of Biological Products DPT Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Wuhan Institute of Biological Products DPT Vaccines Product Portfolio
7.5.5 Wuhan Institute of Biological Products Recent Developments
7.6 Walvax Biotechnology
7.6.1 Walvax Biotechnology Comapny Information
7.6.2 Walvax Biotechnology Business Overview
7.6.3 Walvax Biotechnology DPT Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Walvax Biotechnology DPT Vaccines Product Portfolio
7.6.5 Walvax Biotechnology Recent Developments
7.7 Chengdu Institute of Biological Products
7.7.1 Chengdu Institute of Biological Products Comapny Information
7.7.2 Chengdu Institute of Biological Products Business Overview
7.7.3 Chengdu Institute of Biological Products DPT Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Chengdu Institute of Biological Products DPT Vaccines Product Portfolio
7.7.5 Chengdu Institute of Biological Products Recent Developments
7.8 Minhai Biotechnology
7.8.1 Minhai Biotechnology Comapny Information
7.8.2 Minhai Biotechnology Business Overview
7.8.3 Minhai Biotechnology DPT Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 Minhai Biotechnology DPT Vaccines Product Portfolio
7.8.5 Minhai Biotechnology Recent Developments
8 North America
8.1 North America DPT Vaccines Market Size by Type
8.1.1 North America DPT Vaccines Revenue by Type (2019-2030)
8.1.2 North America DPT Vaccines Sales by Type (2019-2030)
8.1.3 North America DPT Vaccines Price by Type (2019-2030)
8.2 North America DPT Vaccines Market Size by Age
8.2.1 North America DPT Vaccines Revenue by Age (2019-2030)
8.2.2 North America DPT Vaccines Sales by Age (2019-2030)
8.2.3 North America DPT Vaccines Price by Age (2019-2030)
8.3 North America DPT Vaccines Market Size by Country
8.3.1 North America DPT Vaccines Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America DPT Vaccines Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America DPT Vaccines Price by Country (2019-2030)
8.3.4 United States
8.3.5 Canada
9 Europe
9.1 Europe DPT Vaccines Market Size by Type
9.1.1 Europe DPT Vaccines Revenue by Type (2019-2030)
9.1.2 Europe DPT Vaccines Sales by Type (2019-2030)
9.1.3 Europe DPT Vaccines Price by Type (2019-2030)
9.2 Europe DPT Vaccines Market Size by Age
9.2.1 Europe DPT Vaccines Revenue by Age (2019-2030)
9.2.2 Europe DPT Vaccines Sales by Age (2019-2030)
9.2.3 Europe DPT Vaccines Price by Age (2019-2030)
9.3 Europe DPT Vaccines Market Size by Country
9.3.1 Europe DPT Vaccines Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe DPT Vaccines Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe DPT Vaccines Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 China
10.1 China DPT Vaccines Market Size by Type
10.1.1 China DPT Vaccines Revenue by Type (2019-2030)
10.1.2 China DPT Vaccines Sales by Type (2019-2030)
10.1.3 China DPT Vaccines Price by Type (2019-2030)
10.2 China DPT Vaccines Market Size by Age
10.2.1 China DPT Vaccines Revenue by Age (2019-2030)
10.2.2 China DPT Vaccines Sales by Age (2019-2030)
10.2.3 China DPT Vaccines Price by Age (2019-2030)
11 Asia (Excluding China)
11.1 Asia DPT Vaccines Market Size by Type
11.1.1 Asia DPT Vaccines Revenue by Type (2019-2030)
11.1.2 Asia DPT Vaccines Sales by Type (2019-2030)
11.1.3 Asia DPT Vaccines Price by Type (2019-2030)
11.2 Asia DPT Vaccines Market Size by Age
11.2.1 Asia DPT Vaccines Revenue by Age (2019-2030)
11.2.2 Asia DPT Vaccines Sales by Age (2019-2030)
11.2.3 Asia DPT Vaccines Price by Age (2019-2030)
11.3 Asia DPT Vaccines Market Size by Country
11.3.1 Asia DPT Vaccines Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia DPT Vaccines Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia DPT Vaccines Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 Middle East, Africa and Latin America
12.1 MEALA DPT Vaccines Market Size by Type
12.1.1 MEALA DPT Vaccines Revenue by Type (2019-2030)
12.1.2 MEALA DPT Vaccines Sales by Type (2019-2030)
12.1.3 MEALA DPT Vaccines Price by Type (2019-2030)
12.2 MEALA DPT Vaccines Market Size by Age
12.2.1 MEALA DPT Vaccines Revenue by Age (2019-2030)
12.2.2 MEALA DPT Vaccines Sales by Age (2019-2030)
12.2.3 MEALA DPT Vaccines Price by Age (2019-2030)
12.3 MEALA DPT Vaccines Market Size by Country
12.3.1 MEALA DPT Vaccines Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA DPT Vaccines Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA DPT Vaccines Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 Value Chain and Sales Channels Analysis
13.1 DPT Vaccines Value Chain Analysis
13.1.1 DPT Vaccines Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 DPT Vaccines Production Mode & Process
13.2 DPT Vaccines Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 DPT Vaccines Distributors
13.2.3 DPT Vaccines Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
List of Tables
Table 1. Global DPT Vaccines Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. DTaP Major Manufacturers
Table 3. Tdap Major Manufacturers
Table 4. DTwP Major Manufacturers
Table 5. Global DPT Vaccines Market Size Growth Rate by Age (US$ Million), 2019 VS 2023 VS 2030
Table 6. 12 Months Below Major Manufacturers
Table 7. 12 Months Above Major Manufacturers
Table 8. DPT Vaccines Industry Trends
Table 9. DPT Vaccines Industry Drivers
Table 10. DPT Vaccines Industry Opportunities and Challenges
Table 11. DPT Vaccines Industry Restraints
Table 12. Global DPT Vaccines Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 13. Global DPT Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 14. Global DPT Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 15. Global DPT Vaccines Revenue Market Share by Region (2019-2024)
Table 16. Global DPT Vaccines Revenue Market Share by Region (2025-2030)
Table 17. Global DPT Vaccines Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (M Doses)
Table 18. Global DPT Vaccines Sales by Region (2019-2024) & (M Doses)
Table 19. Global DPT Vaccines Sales by Region (2025-2030) & (M Doses)
Table 20. Global DPT Vaccines Sales Market Share by Region (2019-2024)
Table 21. Global DPT Vaccines Sales Market Share by Region (2025-2030)
Table 22. Global DPT Vaccines Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 23. Global DPT Vaccines Revenue Market Share by Manufacturers (2019-2024)
Table 24. Global DPT Vaccines Sales by Manufacturers (US$ Million) & (2019-2024)
Table 25. Global DPT Vaccines Sales Market Share by Manufacturers (2019-2024)
Table 26. Global DPT Vaccines Sales Price (US$/Dose) of Manufacturers (2019-2024)
Table 27. Global DPT Vaccines Key Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 28. Global DPT Vaccines Key Manufacturers Manufacturing Sites & Headquarters
Table 29. Global DPT Vaccines Manufacturers, Product Type & Application
Table 30. Global DPT Vaccines Manufacturers Commercialization Time
Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global DPT Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 33. Global DPT Vaccines Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 34. Global DPT Vaccines Revenue by Type (2019-2024) & (US$ Million)
Table 35. Global DPT Vaccines Revenue by Type (2025-2030) & (US$ Million)
Table 36. Global DPT Vaccines Revenue Market Share by Type (2019-2024)
Table 37. Global DPT Vaccines Revenue Market Share by Type (2025-2030)
Table 38. Global DPT Vaccines Sales by Type 2019 VS 2023 VS 2030 (M Doses)
Table 39. Global DPT Vaccines Sales by Type (2019-2024) & (M Doses)
Table 40. Global DPT Vaccines Sales by Type (2025-2030) & (M Doses)
Table 41. Global DPT Vaccines Sales Market Share by Type (2019-2024)
Table 42. Global DPT Vaccines Sales Market Share by Type (2025-2030)
Table 43. Global DPT Vaccines Price by Type (2019-2024) & (US$/Dose)
Table 44. Global DPT Vaccines Price by Type (2025-2030) & (US$/Dose)
Table 45. Global DPT Vaccines Revenue by Age 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Global DPT Vaccines Revenue by Age (2019-2024) & (US$ Million)
Table 47. Global DPT Vaccines Revenue by Age (2025-2030) & (US$ Million)
Table 48. Global DPT Vaccines Revenue Market Share by Age (2019-2024)
Table 49. Global DPT Vaccines Revenue Market Share by Age (2025-2030)
Table 50. Global DPT Vaccines Sales by Age 2019 VS 2023 VS 2030 (M Doses)
Table 51. Global DPT Vaccines Sales by Age (2019-2024) & (M Doses)
Table 52. Global DPT Vaccines Sales by Age (2025-2030) & (M Doses)
Table 53. Global DPT Vaccines Sales Market Share by Age (2019-2024)
Table 54. Global DPT Vaccines Sales Market Share by Age (2025-2030)
Table 55. Global DPT Vaccines Price by Age (2019-2024) & (US$/Dose)
Table 56. Global DPT Vaccines Price by Age (2025-2030) & (US$/Dose)
Table 57. Sanofi Pasteur Company Information
Table 58. Sanofi Pasteur Business Overview
Table 59. Sanofi Pasteur DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 60. Sanofi Pasteur DPT Vaccines Product Portfolio
Table 61. Sanofi Pasteur Recent Development
Table 62. GSK Company Information
Table 63. GSK Business Overview
Table 64. GSK DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 65. GSK DPT Vaccines Product Portfolio
Table 66. GSK Recent Development
Table 67. Mitsubishi Tanabe Pharma Company Information
Table 68. Mitsubishi Tanabe Pharma Business Overview
Table 69. Mitsubishi Tanabe Pharma DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 70. Mitsubishi Tanabe Pharma DPT Vaccines Product Portfolio
Table 71. Mitsubishi Tanabe Pharma Recent Development
Table 72. KM Biologics Company Information
Table 73. KM Biologics Business Overview
Table 74. KM Biologics DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 75. KM Biologics DPT Vaccines Product Portfolio
Table 76. KM Biologics Recent Development
Table 77. Wuhan Institute of Biological Products Company Information
Table 78. Wuhan Institute of Biological Products Business Overview
Table 79. Wuhan Institute of Biological Products DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 80. Wuhan Institute of Biological Products DPT Vaccines Product Portfolio
Table 81. Wuhan Institute of Biological Products Recent Development
Table 82. Walvax Biotechnology Company Information
Table 83. Walvax Biotechnology Business Overview
Table 84. Walvax Biotechnology DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 85. Walvax Biotechnology DPT Vaccines Product Portfolio
Table 86. Walvax Biotechnology Recent Development
Table 87. Chengdu Institute of Biological Products Company Information
Table 88. Chengdu Institute of Biological Products Business Overview
Table 89. Chengdu Institute of Biological Products DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 90. Chengdu Institute of Biological Products DPT Vaccines Product Portfolio
Table 91. Chengdu Institute of Biological Products Recent Development
Table 92. Minhai Biotechnology Company Information
Table 93. Minhai Biotechnology Business Overview
Table 94. Minhai Biotechnology DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 95. Minhai Biotechnology DPT Vaccines Product Portfolio
Table 96. Minhai Biotechnology Recent Development
Table 97. North America DPT Vaccines Revenue by Type (2019-2024) & (US$ Million)
Table 98. North America DPT Vaccines Revenue by Type (2025-2030) & (US$ Million)
Table 99. North America DPT Vaccines Sales by Type (2019-2024) & (M Doses)
Table 100. North America DPT Vaccines Sales by Type (2025-2030) & (M Doses)
Table 101. North America DPT Vaccines Sales Price by Type (2019-2024) & (US$/Dose)
Table 102. North America DPT Vaccines Sales Price by Type (2025-2030) & (US$/Dose)
Table 103. North America DPT Vaccines Revenue by Age (2019-2024) & (US$ Million)
Table 104. North America DPT Vaccines Revenue by Age (2025-2030) & (US$ Million)
Table 105. North America DPT Vaccines Sales by Age (2019-2024) & (M Doses)
Table 106. North America DPT Vaccines Sales by Age (2025-2030) & (M Doses)
Table 107. North America DPT Vaccines Sales Price by Age (2019-2024) & (US$/Dose)
Table 108. North America DPT Vaccines Sales Price by Age (2025-2030) & (US$/Dose)
Table 109. North America DPT Vaccines Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 110. North America DPT Vaccines Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 111. North America DPT Vaccines Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 112. North America DPT Vaccines Sales by Country (2019 VS 2023 VS 2030) & (M Doses)
Table 113. North America DPT Vaccines Sales by Country (2019-2024) & (M Doses)
Table 114. North America DPT Vaccines Sales by Country (2025-2030) & (M Doses)
Table 115. North America DPT Vaccines Sales Price by Country (2019-2024) & (US$/Dose)
Table 116. North America DPT Vaccines Sales Price by Country (2025-2030) & (US$/Dose)
Table 117. US DPT Vaccines Revenue (2019-2030) & (US$ Million)
Table 118. Canada DPT Vaccines Revenue (2019-2030) & (US$ Million)
Table 119. Europe DPT Vaccines Revenue by Type (2019-2024) & (US$ Million)
Table 120. Europe DPT Vaccines Revenue by Type (2025-2030) & (US$ Million)
Table 121. Europe DPT Vaccines Sales by Type (2019-2024) & (M Doses)
Table 122. Europe DPT Vaccines Sales by Type (2025-2030) & (M Doses)
Table 123. Europe DPT Vaccines Sales Price by Type (2019-2024) & (US$/Dose)
Table 124. Europe DPT Vaccines Sales Price by Type (2025-2030) & (US$/Dose)
Table 125. Europe DPT Vaccines Revenue by Age (2019-2024) & (US$ Million)
Table 126. Europe DPT Vaccines Revenue by Age (2025-2030) & (US$ Million)
Table 127. Europe DPT Vaccines Sales by Age (2019-2024) & (M Doses)
Table 128. Europe DPT Vaccines Sales by Age (2025-2030) & (M Doses)
Table 129. Europe DPT Vaccines Sales Price by Age (2019-2024) & (US$/Dose)
Table 130. Europe DPT Vaccines Sales Price by Age (2025-2030) & (US$/Dose)
Table 131. Europe DPT Vaccines Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 132. Europe DPT Vaccines Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 133. Europe DPT Vaccines Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 134. Europe DPT Vaccines Sales by Country (2019 VS 2023 VS 2030) & (M Doses)
Table 135. Europe DPT Vaccines Sales by Country (2019-2024) & (M Doses)
Table 136. Europe DPT Vaccines Sales by Country (2025-2030) & (M Doses)
Table 137. Europe DPT Vaccines Sales Price by Country (2019-2024) & (US$/Dose)
Table 138. Europe DPT Vaccines Sales Price by Country (2025-2030) & (US$/Dose)
Table 139. Germany DPT Vaccines Revenue (2019-2030) & (US$ Million)
Table 140. France DPT Vaccines Revenue (2019-2030) & (US$ Million)
Table 141. DPT Vaccines Revenue (2019-2030) & (US$ Million)
Table 142. DPT Vaccines Revenue (2019-2030) & (US$ Million)
Table 143. DPT Vaccines Revenue (2019-2030) & (US$ Million)
Table 144. China DPT Vaccines Revenue by Type (2019-2024) & (US$ Million)
Table 145. China DPT Vaccines Revenue by Type (2025-2030) & (US$ Million)
Table 146. China DPT Vaccines Sales by Type (2019-2024) & (M Doses)
Table 147. China DPT Vaccines Sales by Type (2025-2030) & (M Doses)
Table 148. China DPT Vaccines Sales Price by Type (2019-2024) & (US$/Dose)
Table 149. China DPT Vaccines Sales Price by Type (2025-2030) & (US$/Dose)
Table 150. China DPT Vaccines Revenue by Age (2019-2024) & (US$ Million)
Table 151. China DPT Vaccines Revenue by Age (2025-2030) & (US$ Million)
Table 152. China DPT Vaccines Sales by Age (2019-2024) & (M Doses)
Table 153. China DPT Vaccines Sales by Age (2025-2030) & (M Doses)
Table 154. China DPT Vaccines Sales Price by Age (2019-2024) & (US$/Dose)
Table 155. China DPT Vaccines Sales Price by Age (2025-2030) & (US$/Dose)
Table 156. Asia DPT Vaccines Revenue by Type (2019-2024) & (US$ Million)
Table 157. Asia DPT Vaccines Revenue by Type (2025-2030) & (US$ Million)
Table 158. Asia DPT Vaccines Sales by Type (2019-2024) & (M Doses)
Table 159. Asia DPT Vaccines Sales by Type (2025-2030) & (M Doses)
Table 160. Asia DPT Vaccines Sales Price by Type (2019-2024) & (US$/Dose)
Table 161. Asia DPT Vaccines Sales Price by Type (2025-2030) & (US$/Dose)
Table 162. Asia DPT Vaccines Revenue by Age (2019-2024) & (US$ Million)
Table 163. Asia DPT Vaccines Revenue by Age (2025-2030) & (US$ Million)
Table 164. Asia DPT Vaccines Sales by Age (2019-2024) & (M Doses)
Table 165. Asia DPT Vaccines Sales by Age (2025-2030) & (M Doses)
Table 166. Asia DPT Vaccines Sales Price by Age (2019-2024) & (US$/Dose)
Table 167. Asia DPT Vaccines Sales Price by Age (2025-2030) & (US$/Dose)
Table 168. Asia DPT Vaccines Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 169. Asia DPT Vaccines Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 170. Asia DPT Vaccines Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 171. Asia DPT Vaccines Sales by Country (2019 VS 2023 VS 2030) & (M Doses)
Table 172. Asia DPT Vaccines Sales by Country (2019-2024) & (M Doses)
Table 173. Asia DPT Vaccines Sales by Country (2025-2030) & (M Doses)
Table 174. Asia DPT Vaccines Sales Price by Country (2019-2024) & (US$/Dose)
Table 175. Asia DPT Vaccines Sales Price by Country (2025-2030) & (US$/Dose)
Table 176. Japan DPT Vaccines Revenue (2019-2030) & (US$ Million)
Table 177. South Korea DPT Vaccines Revenue (2019-2030) & (US$ Million)
Table 178. DPT Vaccines Revenue (2019-2030) & (US$ Million)
Table 179. DPT Vaccines Revenue (2019-2030) & (US$ Million)
Table 180. DPT Vaccines Revenue (2019-2030) & (US$ Million)
Table 181. DPT Vaccines Revenue (2019-2030) & (US$ Million)
Table 182. DPT Vaccines Revenue (2019-2030) & (US$ Million)
Table 183. DPT Vaccines Revenue (2019-2030) & (US$ Million)
Table 184. MEALA DPT Vaccines Revenue by Type (2019-2024) & (US$ Million)
Table 185. MEALA DPT Vaccines Revenue by Type (2025-2030) & (US$ Million)
Table 186. MEALA DPT Vaccines Sales by Type (2019-2024) & (M Doses)
Table 187. MEALA DPT Vaccines Sales by Type (2025-2030) & (M Doses)
Table 188. MEALA DPT Vaccines Sales Price by Type (2019-2024) & (US$/Dose)
Table 189. MEALA DPT Vaccines Sales Price by Type (2025-2030) & (US$/Dose)
Table 190. MEALA DPT Vaccines Revenue by Age (2019-2024) & (US$ Million)
Table 191. MEALA DPT Vaccines Revenue by Age (2025-2030) & (US$ Million)
Table 192. MEALA DPT Vaccines Sales by Age (2019-2024) & (M Doses)
Table 193. MEALA DPT Vaccines Sales by Age (2025-2030) & (M Doses)
Table 194. MEALA DPT Vaccines Sales Price by Age (2019-2024) & (US$/Dose)
Table 195. MEALA DPT Vaccines Sales Price by Age (2025-2030) & (US$/Dose)
Table 196. MEALA DPT Vaccines Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 197. MEALA DPT Vaccines Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 198. MEALA DPT Vaccines Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 199. MEALA DPT Vaccines Sales by Country (2019 VS 2023 VS 2030) & (M Doses)
Table 200. MEALA DPT Vaccines Sales by Country (2019-2024) & (M Doses)
Table 201. MEALA DPT Vaccines Sales by Country (2025-2030) & (M Doses)
Table 202. MEALA DPT Vaccines Sales Price by Country (2019-2024) & (US$/Dose)
Table 203. MEALA DPT Vaccines Sales Price by Country (2025-2030) & (US$/Dose)
Table 204. Mexico DPT Vaccines Revenue (2019-2030) & (US$ Million)
Table 205. Brazil DPT Vaccines Revenue (2019-2030) & (US$ Million)
Table 206. Israel DPT Vaccines Revenue (2019-2030) & (US$ Million)
Table 207. Argentina DPT Vaccines Revenue (2019-2030) & (US$ Million)
Table 208. Colombia DPT Vaccines Revenue (2019-2030) & (US$ Million)
Table 209. Turkey DPT Vaccines Revenue (2019-2030) & (US$ Million)
Table 210. Saudi Arabia DPT Vaccines Revenue (2019-2030) & (US$ Million)
Table 211. UAE DPT Vaccines Revenue (2019-2030) & (US$ Million)
Table 212. Key Raw Materials
Table 213. Raw Materials Key Suppliers
Table 214. DPT Vaccines Distributors List
Table 215. DPT Vaccines Customers List
Table 216. Research Programs/Design for This Report
Table 217. Authors List of This Report
Table 218. Secondary Sources
Table 219. Primary Sources
List of Figures
Figure 1. DPT Vaccines Product Picture
Figure 2. Global DPT Vaccines Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global DPT Vaccines Market Size Share 2019 VS 2023 VS 2030
Figure 4. DTaP Picture
Figure 5. Tdap Picture
Figure 6. DTwP Picture
Figure 7. Global DPT Vaccines Market Size Growth Rate by Age (US$ Million), 2019 VS 2023 VS 2030
Figure 8. Global DPT Vaccines Market Size Share 2019 VS 2023 VS 2030
Figure 9. 12 Months Below Picture
Figure 10. 12 Months Above Picture
Figure 11. Global DPT Vaccines Revenue (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global DPT Vaccines Revenue (2019-2030) & (US$ Million)
Figure 13. Global DPT Vaccines Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 14. Global DPT Vaccines Revenue Market Share by Region: 2023 Versus 2030
Figure 15. Global DPT Vaccines Revenue Market Share by Region (2019-2030)
Figure 16. Global DPT Vaccines Sales (2019-2030) & (M Doses)
Figure 17. Global DPT Vaccines Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (M Doses)
Figure 18. Global DPT Vaccines Sales Market Share by Region (2019-2030)
Figure 19. US & Canada DPT Vaccines Sales YoY (2019-2030) & (M Doses)
Figure 20. Europe DPT Vaccines Sales YoY (2019-2030) & (M Doses)
Figure 21. China DPT Vaccines Sales YoY (2019-2030) & (M Doses)
Figure 22. Asia (Excluding China) DPT Vaccines Sales YoY (2019-2030) & (M Doses)
Figure 23. Middle East, Africa and Latin America (Excluding China) DPT Vaccines Sales YoY (2019-2030) & (M Doses)
Figure 24. Global DPT Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2023
Figure 25. Global DPT Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2023
Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 27. Global DPT Vaccines Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 28. Global DPT Vaccines Revenue Market Share by Type 2019 VS 2023 VS 2030
Figure 29. Global DPT Vaccines Revenue Market Share by Type (2019-2030)
Figure 30. Global DPT Vaccines Sales by Type (2019 VS 2023 VS 2030) & (M Doses)
Figure 31. Global DPT Vaccines Sales Market Share by Type 2019 VS 2023 VS 2030
Figure 32. Global DPT Vaccines Sales Market Share by Type (2019-2030)
Figure 33. Global DPT Vaccines Revenue by Age (2019 VS 2023 VS 2030) & (US$ Million)
Figure 34. Global DPT Vaccines Revenue Market Share by Application 2019 VS 2023 VS 2030
Figure 35. Global DPT Vaccines Revenue Market Share by Age (2019-2030)
Figure 36. Global DPT Vaccines Sales by Age (2019 VS 2023 VS 2030) & (M Doses)
Figure 37. Global DPT Vaccines Sales Market Share by Application 2019 VS 2023 VS 2030
Figure 38. Global DPT Vaccines Sales Market Share by Age (2019-2030)
Figure 39. North America DPT Vaccines Revenue Share by Type (2019-2030)
Figure 40. North America DPT Vaccines Sales Share by Type (2019-2030)
Figure 41. North America DPT Vaccines Revenue Share by Age (2019-2030)
Figure 42. North America DPT Vaccines Sales Share by Age (2019-2030)
Figure 43. North America DPT Vaccines Revenue Share by Country (2019-2030)
Figure 44. North America DPT Vaccines Sales Share by Country (2019-2030)
Figure 45. Europe DPT Vaccines Revenue Share by Type (2019-2030)
Figure 46. Europe DPT Vaccines Sales Share by Type (2019-2030)
Figure 47. Europe DPT Vaccines Revenue Share by Age (2019-2030)
Figure 48. Europe DPT Vaccines Sales Share by Age (2019-2030)
Figure 49. Europe DPT Vaccines Revenue Share by Country (2019-2030)
Figure 50. Europe DPT Vaccines Sales Share by Country (2019-2030)
Figure 51. China DPT Vaccines Revenue Share by Type (2019-2030)
Figure 52. China DPT Vaccines Sales Share by Type (2019-2030)
Figure 53. China DPT Vaccines Revenue Share by Age (2019-2030)
Figure 54. China DPT Vaccines Sales Share by Age (2019-2030)
Figure 55. Asia DPT Vaccines Revenue Share by Type (2019-2030)
Figure 56. Asia DPT Vaccines Sales Share by Type (2019-2030)
Figure 57. Asia DPT Vaccines Revenue Share by Age (2019-2030)
Figure 58. Asia DPT Vaccines Sales Share by Age (2019-2030)
Figure 59. Asia DPT Vaccines Revenue Share by Country (2019-2030)
Figure 60. Asia DPT Vaccines Sales Share by Country (2019-2030)
Figure 61. MEALA DPT Vaccines Revenue Share by Type (2019-2030)
Figure 62. MEALA DPT Vaccines Sales Share by Type (2019-2030)
Figure 63. MEALA DPT Vaccines Revenue Share by Age (2019-2030)
Figure 64. MEALA DPT Vaccines Sales Share by Age (2019-2030)
Figure 65. MEALA DPT Vaccines Revenue Share by Country (2019-2030)
Figure 66. MEALA DPT Vaccines Sales Share by Country (2019-2030)
Figure 67. DPT Vaccines Value Chain
Figure 68. Manufacturing Cost Structure
Figure 69. DPT Vaccines Production Mode & Process
Figure 70. Direct Comparison with Distribution Share
Figure 71. Distributors Profiles
Figure 72. Years Considered
Figure 73. Research Process
Figure 74. Key Executives Interviewed
